Corporate taxation has become an important issue in the U.S., as budget deficits loom and an important election approaches. Many U.S. companies have said that high corporate income tax is onerous and reduces their ability to compete globally.
Photo courtesy of Raw Pixel (Unsplash.com)
According to USA Today analysis of S&P Capital IQ data, however, there were at least 20 companies in the Standard & Poor’s 500 that reported paying an effective tax rate of 0 percent or lower for the second quarter of 2014. To be included in the analysis, the companies had to report positive earnings, including unusual items, before taxes.
One such company was drug-producing giant Merck, which had a negative effective tax rate of 7.5 percent for the second quarter, according to USA Today. In other words, taxpayers gave the company the equivalent of 7.5 percent of its quarterly profits in tax credits. Merck’s pre-tax income rose 52 percent during the quarter, coming to $1.9 billion.
This anomalous tax rate was attributed to the “beneficial impact of foreign earnings” in the company’s filing, but Merck also got a significant one-time tax benefit from an option exercise that involved AstraZeneca’s purchase of its interest in a partnership, the news source explained. AstraZeneca has also been under public scrutiny with regards to corporate tax practices.
President Barack Obama and other liberals have been making corporate taxation a major issue ahead of the 2014 midterm elections. Both sides of Congress agree that tax code reform is necessary, but many analysts agree that the political deadlock will prevent anything from happening before the elections determine the shape of the next two years.
As tax attorneys for Scarinci Hollenbeck, a regional business law firm with offices in New York, New Jersey, and Washington D.C., James F. McDonough and I are acclimated with corporate culture and the goings-on of corporations regarding income taxes. Check out some of latest post on this hot-button topic:
Section 363 Sales in Bankruptcy: What Businesses, Lenders, and Buyers Need to Know
When a company enters Chapter 11 bankruptcy, many assume the process will culminate in a lengthy reorganization plan. However, distressed businesses are increasingly being sold through a different mechanism — a sale under Section 363 of the United States Bankruptcy Code. A Section 363 sale allows a company, as a debtor-in-possession in bankruptcy, to sell […]
Zoning Laws Explained: What You Need to Know Before Buying Property
Before buying property, it is critical to determine whether local zoning laws may affect your plans. If you plan to redevelop the property, you will want to confirm that local zoning regulations permit development as intended. If acquiring property that is already developed, you must verify that the use is permitted in the underlying zoning […]
Special Needs Trusts in New Jersey: Planning for Your Loved One’s Future
For parents of a child with a disability, estate planning raises concerns that go well beyond deciding who will inherit their assets. Parents may spend years making sure their child has the right care, services, and support. Eventually, they must also confront a difficult question: Who will take over when they can no longer do […]
What Every Real Estate Investor Should Know Before Buying a Rental Property
Before buying a New Jersey rental property, an investor should verify realistic operating numbers, the property’s legal and regulatory status, lead-based paint and flood compliance, the existing leases and tenant protections, and the right ownership structure. A rental property is more than a piece of real estate; it is an operating business subject to legal, […]
Can You Change an Irrevocable Trust in New Jersey?
In New Jersey, an irrevocable trust can sometimes be modified even though its name suggests otherwise, and one of the primary tools for doing so is a process called decanting. Whether decanting is available depends on the specific terms of the trust and the discretion given to the trustee. Key takeaways: New Jersey has no […]
How Intellectual Property Valuation Will Impact Business Transactions
Intellectual property valuation determines the monetary value of a business’s IP assets, and it drives outcomes in licensing deals, joint ventures, mergers and acquisitions, financing, and ownership disputes. The most valuable assets of a business are often the things that cannot be seen or touched: a proprietary process, a copyrighted work, brand recognition, or the […]
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!
